Syndax Pharmaceuticals, Inc. SNDX
$12.90
-5.49%
at last close
Analyst Consensus
- Consensus Rating
- Buy (9 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $42.00
- Implied Upside
- +225.6%
- Price Target Range
- $33.00 – $57.00
- Analysts (12 mo)
- 9
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-13 | HC Wainwright & Co.Andres Y. Maldonado |
Reiterates | Buy | $38 |
| 2026-08-21 | UBSDavid Dai |
Maintains | Buy | $37 → $33 |
| 2026-08-11 | JP MorganAnupam Rama |
Maintains | Overweight | $44 → $40 |
| 2026-08-05 | HC Wainwright & Co.Andres Y. Maldonado |
Maintains | Buy | $40 → $38 |
| 2026-07-15 | HC Wainwright & Co.Andres Y. Maldonado |
Reiterates | Buy | $40 |
| 2026-06-12 | HC Wainwright & Co.Andres Y. Maldonado |
Reiterates | Buy | $40 |
| 2026-05-22 | HC Wainwright & Co.Andres Y. Maldonado |
Reiterates | Buy | $40 |
| 2026-05-13 | UBSDavid Dai |
Maintains | Buy | $38 → $37 |
| 2026-05-01 | BarclaysEtzer Darout |
Maintains | Overweight | $35 → $37 |
| 2026-04-01 | Goldman SachsCorinne Johnson |
Maintains | Buy | $28 → $34 |
| 2026-03-31 | MizuhoSalim Syed |
Maintains | Outperform | $45 → $43 |
| 2026-03-30 | JefferiesFaisal Khurshid |
Assumes | Buy | $48 → $40 |
| 2026-03-09 | JP MorganAnupam Rama |
Maintains | Overweight | $33 → $45 |
| 2026-03-02 | CitigroupYigal Nochomovitz |
Maintains | Buy | $51 → $57 |
| 2025-12-09 | BTIGJustin Zelin |
Reiterates | Buy | $56 |
| 2025-11-24 | BarclaysEtzer Darout |
Maintains | Overweight | $22 → $35 |
| 2025-11-12 | JP MorganAnupam Rama |
Maintains | Overweight | $40 → $33 |
| 2025-11-04 | UBSDavid Dai |
Maintains | Buy | $35 → $38 |
| 2025-11-04 | BarclaysPeter Lawson |
Maintains | Overweight | $19 → $22 |
| 2025-10-27 | HC Wainwright & Co.Andres Y. Maldonado |
Reiterates | Buy | $40 |
| 2025-10-27 | BTIGJustin Zelin |
Reiterates | Buy | $56 |
| 2025-10-16 | HC Wainwright & Co.Andres Y. Maldonado |
Assumes | Buy | $40 |
| 2025-09-19 | BTIGJustin Zelin |
Reiterates | Buy | $56 |
| 2025-09-10 | StifelBradley Canino |
Reinstates | Buy | $44 |
| 2025-09-05 | Goldman SachsCorinne Johnson |
Maintains | Buy | $20 → $24 |
| 2025-09-04 | GuggenheimBradley Canino |
Initiates coverage on | Buy | $34 |
| 2025-08-05 | CitigroupYigal Nochomovitz |
Maintains | Buy | $46 → $51 |
| 2025-08-05 | BTIGJustin Zelin |
Maintains | Buy | $43 → $56 |
| 2025-07-15 | UBSDavid Dai |
Maintains | Buy | $37 → $35 |
| 2025-07-10 | Goldman SachsCorinne Johnson |
Initiates coverage on | Buy | $18 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $12.90
- Market Cap
- $1.15 billion
- 52-Week Range
- $12.81 – $25.59
- Average Volume
- 2.08 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.